CEA Industries Announces That YZi Labs’ Request to Fix Record Date for Proposed Consent Solicitation Is Deficient

Rhea-AI Summary

{"summary":"","positive":[],"negative":[],"faq":[]}

News Market Reaction – BNC

+0.94%

1 alert

+0.94% News Effect

On the day this news was published, BNC gained 0.94%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Net loss: $(106.6)M EPS: $(2.00) Unrealized loss: $159.8M +5 more

8 metrics

Net loss $(106.6)M Fiscal Q3 2026 results

EPS $(2.00) Fiscal Q3 2026 results

Unrealized loss $159.8M Driven mainly by BNB decline

BNB price decline 28% BNB decline driving unrealized loss in Q3 2026

Share repurchases 2,176,217 shares YTD repurchases disclosed with Q3 2026 results

YZi Labs common shares 2,150,481 shares Direct beneficial ownership disclosed in DFAN14A filings

Beneficial ownership cap 4.99% Limit on warrant exercisability in DFAN14A filings

Non-exercisability window 60 days Warrants not expected to be exercisable within 60 days

Market Reality Check

Price: $3.21 Vol: Volume 142,323 is about h...

low vol

$3.21 Last Close

Volume Volume 142,323 is about half of the 20-day average of 267,908, suggesting a relatively muted pre-news setup. low

Technical Shares at $3.18 are trading below the 200-day MA of $8.77 and remain far under the 52-week high of $31.62.

Peers on Argus

BNC is up 2.58% while only one momentum peer (TWI) appears and is down ~1.94%, i...

1 Down

BNC is up 2.58% while only one momentum peer (TWI) appears and is down ~1.94%, indicating the move is stock-specific rather than an Industrials sector rotation.

Historical Context

5 past events · Latest: Mar 16 (Negative)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 16	Earnings and CEO change	Negative	-0.9%	Large BNB-driven net loss and announced CEO transition weighed on shares.
Mar 10	CFO appointment	Positive	-4.8%	New CFO with capital markets experience but shares fell after the announcement.
Feb 25	Shareholder letter	Positive	+1.6%	CEO highlighted conservative balance sheet and governance, with a modest price gain.
Feb 24	Governance dispute	Neutral	+1.6%	Company commentary on YZi Labs’ side agreement amid ongoing activist tensions.
Feb 18	Asset agreement revision	Positive	-4.2%	Board moved to revise asset management fees and terms, but shares declined.

Pattern Detected

Recent governance- and strategy-related headlines show mixed price reactions, with both positive and negative moves following board and activist updates.

Recent Company History

Over the last few months, BNC’s news flow has centered on heavy BNB-related losses, governance, and an activist campaign. An earnings release on Mar 16, 2026 reported a large net loss tied to BNB, with a modest negative reaction. Governance actions around the Asset Management Agreement and responses to YZi Labs’ activism have produced both positive and negative moves. Today’s notice that YZi Labs’ record-date request was deemed deficient fits into this ongoing control contest and board-focused narrative.

Market Pulse Summary

This announcement details that BNC’s board deemed YZi Labs’ record-date request for a consent solici...

Analysis

This announcement details that BNC’s board deemed YZi Labs’ record-date request for a consent solicitation deficient under the company’s bylaws, temporarily preventing that solicitation from proceeding. It extends an ongoing activist contest that has already generated multiple DFAN14A and 8-K filings and governance-focused press releases. Investors monitoring this situation may focus on future revisions to the request, additional board changes, and any further updates on the company’s BNB-driven financial results and asset management arrangements. Future disclosures and filings will be important reference points.

Key Terms

consent solicitation, record date, fiduciary duties, beneficial ownership limitation, +2 more

6 terms

consent solicitation regulatory

"YZi Labs’ proposed consent solicitation (the “Request Letter”)."

A consent solicitation is a formal request sent to shareholders or creditors asking them to sign off on a proposed corporate change—such as altering governance rules, approving a deal, or waiving contract terms—without holding a full meeting. It matters to investors because it can quickly change their rights, voting power or the company’s direction, much like asking neighbors to sign a petition to alter a shared fence rather than discussing it at a community meeting.

record date regulatory

"to set a record date for determining the stockholders entitled to consent"

The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.

fiduciary duties regulatory

"Following a careful review of the Request Letter in accordance with its fiduciary duties"

Fiduciary duties are the legal and ethical responsibilities that company directors, officers, or financial advisors have to put shareholders’ interests ahead of their own, acting with honesty, care, and loyalty. Think of it like a guardian managing someone’s money: choices must prioritize the owner’s benefit, avoid conflicts, and be made with prudent judgment; investors rely on these duties to ensure decisions aren’t self‑serving and to provide grounds for legal action if abused.

beneficial ownership limitation regulatory

"Those warrants are subject to a 4.99% beneficial ownership limitation and are not expected"

A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.

pre-funded warrant financial

"warrants exercisable into 7,750,510 Pre-Funded Warrant shares, 9,900,991 Stapled"

A pre-funded warrant is a financial instrument that gives the holder the right to buy shares of a company's stock at a set price, with most of the purchase cost already paid upfront. It functions like a nearly fully paid option, allowing investors to secure shares quickly while minimizing the amount of additional money they need to invest later. This helps investors gain ownership rights efficiently, often used to avoid certain regulatory restrictions or to prepare for future stock purchases.

schedule 13d regulatory

"as disclosed in Amendment No. 3 to a Schedule 13D filed on"

A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.

AI-generated analysis. Not financial advice.

Request omitted highly material disclosures required under the Company’s bylaws

YZi Labs may not proceed with its proposed consent solicitation

Stockholders are not required to take any action at this time

LOUISVILLE, CO, March 24, 2026 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: BNC) ("BNC" or the "Company") today announced that its Board of Directors (the “Board”) has completed its review of the request received from YZILabs Management Ltd. (“YZi Labs”) to set a record date for determining the stockholders entitled to consent in connection with YZi Labs’ proposed consent solicitation (the “Request Letter”).

The Board has determined that YZi Labs’ Request Letter is deficient because it omitted material information required under the Company’s bylaws. Accordingly, the Board has not set a record date, and YZi Labs may not proceed with its proposed consent solicitation.

The Board issued the following statement:

Like many public companies, the Company’s bylaws establish a clear and straightforward process for stockholders to act outside of the regular process of a stockholder meeting. These provisions are designed to ensure orderly and informed consent solicitations. Among other provisions, the Company’s bylaws require a stockholder seeking to solicit consents from other stockholders to request that a record date be fixed and provide certain information about itself and related parties.

Following a careful review of the Request Letter in accordance with its fiduciary duties, the Board determined that YZi Labs’ Request Letter failed to satisfy the clear and substantive requirements of the Company’s bylaws by omitting highly material information on important topics. For example, the Request Letter failed to disclose the number of BNB held by YZi Labs, its related persons and its nominees, and omitted details about financial relationships between YZi Labs and its nominees—at least six of whom have significant connections to YZi Labs.

The omitted disclosures are critical to ensuring that the Board and stockholders are fully informed about potential conflicts of interest and incentives that could be adverse to stockholder interests if YZi Labs takes control of the Board. With these, the Board and stockholders cannot evaluate whether YZi Labs’ nominees could exercise independent judgment, rather than being beholden to YZi Labs’ separate interests.

The Board remains focused on governing BNC in the best interests of the Company and all stockholders. Should YZi Labs submit a new request letter, the Board will review it for compliance with the bylaws and, if it provides all required information and is otherwise in the proper form, the Company will announce a record date for YZi Labs’ consent solicitation.

Stockholders are not required to take any action at this time.

About CEA Industries Inc.

CEA Industries Inc. (Nasdaq: BNC) is a growth-oriented company that has focused on building category-leading businesses in consumer markets, including building and managing the world's largest corporate treasury of BNB.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements.” The statements in this press release that are not purely historical are forward-looking statements which involve risks and uncertainties, including forward-looking statements regarding BNC’s expectations or beliefs regarding the Company’s position as the largest BNB treasury in the world. BNC wishes to caution readers that these forward-looking statements may be affected by the risks and uncertainties in BNC’s business, as well as other important factors that may have affected and could in the future affect BNC’s actual results and could cause BNC’s actual results for subsequent periods to differ materially from those expressed in any forward-looking statement made by or on behalf of BNC. In evaluating these forward-looking statements, readers should consider various risk factors, which include, but are not limited to, BNC’s ability to keep pace with new technology and changing market needs; BNC’s ability to finance its current business and proposed future business, including the ability to finance the continued acquisition of BNB; the competitive environment of BNC’s business; and the future value and adoption of BNB. Actual future performance outcomes and results may differ materially from those expressed in forward-looking statements. Forward-looking statements are subject to numerous conditions and risks, many of which are beyond BNC’s control. In addition, these forward-looking statements and the information in this press release is qualified in its entirety by cautionary statements and risk factor disclosures contained in BNC’s filings with the SEC, including BNC’s Forms 10-Q filed with the SEC on March 16, 2026 and December 15, 2025, Form 10-K filed with the SEC on March 27, 2025, and Form 10-KT filed with the SEC on July 25, 2025, each as may be amended or supplemented from time to time. Copies of BNC’s filings with the SEC are available on the SEC’s website at www.sec.gov. BNC undertakes no obligation to update these statements for revisions or changes after the date of this press release, except as required by law.

Important Additional Information and Where to Find It

The Company intends to file a consent revocation statement on Schedule 14A, an accompanying YELLOW consent revocation card and other relevant documents with the SEC in connection with YZi Labs’ consent solicitation. THE COMPANY’S STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ THE COMPANY’S DEFINITIVE CONSENT REVOCATION STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), THE ACCOMPANYING YELLOW CONSENT REVOCATION CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Stockholders may obtain free copies of the definitive consent revocation statement, an accompanying YELLOW consent revocation card, any amendments or supplements to the consent revocation statement and other documents that the Company files with the SEC at no charge from the SEC’s website at www.sec.gov. Copies will also be available at no charge by scrolling to the “SEC Filings” section of the Company’s website at https://ceaindustries.com/investors.html.

Certain Information Regarding Participants in the Solicitation

The Company, its directors (Anthony K. McDonald, Nicholas J. Etten, Carly E. Howard, Hans Thomas, Annemarie Tierney, and Glenn Tyranski) and certain of its executive officers (David Namdar and Brent Miller) are deemed to be “participants” (as defined in Schedule 14A under the Securities Exchange Act of 1934, as amended) in the solicitation of consent revocations from the Company’s stockholders in connection with YZi Labs’ consent solicitation. Information about the names of the Company’s directors and officers, their respective interests in the Company, by security holdings or otherwise, and their respective compensation is set forth in the “Information about our Directors” and “Executive Officers” sections in Part III, Item 10 – Directors, Executive Officers and Corporate Governance of the Company’s Transition Report on Form 10-KT for the transition period from January 1, 2025 to April 30, 2025 (the “Form 10-KT”), in Part III, Item 11 – Executive Compensation of the Form 10-KT, in Part III, Item 12 – Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters of the Form 10-KT and in Current Reports on Form 8-K filed with the SEC on August 8, 2025, October 7, 2025 and November 28, 2025. Supplemental information regarding the participants’ holdings of the Company’s securities can be found in SEC filings on Statements of Change in Ownership on Form 3 and Form 4. Any subsequent updates following the date hereof to the information regarding the identity of potential participants and their direct or indirect interests, by security holdings or otherwise, will be set forth in the Company’s consent revocation statement on Schedule 14A and other materials to be filed with the SEC in connection with YZi Labs’ consent solicitation, if and when they become available. These documents will be available at no charge as described above.

CEA Industries Media Inquiries:
Edelman Smithfield CEA@edelmansmithfield.com
CEA Industries Investor Relations: james@haydenir.com